Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 10—October 2007
Research

Personal Protective Equipment and Antiviral Drug Use during Hospitalization for Suspected Avian or Pandemic Influenza1

Ashwin Swaminathan*, Rhea Martin*, Sandi Gamon*, Craig Aboltins†, Eugene Athan‡, George Braitberg*, Michael G. Catton§, Louise Cooley¶, Dominic E. Dwyer#, Deidre Edmonds*, Damon P. Eisen**, Kelly Hosking*, Andrew J. Hughes‡, Paul D. Johnson*††, Andrew V Maclean‡‡, Mary O’Reilly‡‡, S. Erica Peters§§, Rhonda L. Stuart¶¶, Rodney Moran##, and M. Lindsay Grayson*††***Comments to Author 
Author affiliations: *Austin Health, Melbourne, Victoria, Australia; †St. Vincent’s Health, Melbourne, Victoria, Australia; ‡Barwon Health, Geelong, Victoria, Australia; §Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia; ¶Royal Hobart Hospital, Hobart, Tasmania, Australia; #Westmead Hospital, Sydney, New South Wales, Australia; **Royal Melbourne Hospital, Melbourne, Victoria, Australia; ††University of Melbourne, Melbourne, Victoria, Australia; ‡‡Box Hill Hospital–Eastern Health, Melbourne, Victoria, Australia; §§Western Hospital, Melbourne, Victoria, Australia; ¶¶Monash Medical Centre–Southern Health, Melbourne, Victoria, Australia; ##Department of Human Services, Melbourne, Victoria, Australia; ***Monash University, Melbourne, Victoria, Australia;

Main Article

Table 4

Actual and total opportunities for PPE item use by HCWs during the study period*

PPE item type Actual PPE use (total opportunities for PPE item use) by hospital†
 Compliance,¶ %
A B C D E F G H‡ I‡ Mean§
N95 masks 20 (22) 11 (16) 18 (18) 20 (22) 16 (17) 23 (23) 18 (18) 6 
(8) 8 
(11) 18 
(19.4) 93
Gowns 18 (29) 11 (18) 17 (21) 19 (24) 15 (17) 20 (25) 20 (21) 6 
(11) 9 
(12) 17.1 
(22.1) 77
Gloves 27 (35) 12 (20) 18 (21) 21 (27) 19 (21) 23 (25) 26 (27) 8 
(11) 10 (13) 20.9 
(25.1) 83
Eye protection 4 
(20) 4 
(13) 14 (16) 18 (21) 14 (16) 21 (22) 17 (17) 3 
(7) 4 
(7) 13.1 
(17.9) 73
Shoe protection# – 4 2 – 9 – – – 1 2.1
Hats# – 1 13 – 14 – – – 5 4

*PPE, personal protective equipment; HCWs, healthcare workers
†See Table 1 for definitions.
‡Incomplete data as hospitals H and I terminated simulation after 2.5 h.
§Excludes data from hospitals H and I.
¶Actual/total opportunities for PPE item use.
#Use of shoe protection and hats not proscribed by the World Health Organization for routine use; data recorded only if these items were used.

Main Article

1This research was presented in part at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, September 17-20, 2007.

Page created: July 02, 2010
Page updated: July 02, 2010
Page reviewed: July 02, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external